Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory randomized crossover study of new versus marketed flurbiprofen throat spray in healthy adults
NL-OMON48429Active, not recruiting
- Sponsor
- Reckitt
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of flurbiprofen in pharyngitis (6 arms), sponsored by Reckitt. Primary endpoints: Changes in oral mucosa and HSE irritancy questionnaire responses. Started Mar 2019; status: active, not recruiting.
02
Drugs
flurbiprofen
03
Conditions
pharyngitis
Beyond the preview
Go deeper on NL-OMON48429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48429.